Abstract
Industry 4.0 in the pharmaceutical, medical devices, and healthcare sectors could have a significant impact as they can help maximize productivity by analyzing the data of patients. The application of Industry 4.0 technologies to the pharma, medical, and healthcare sectors may also play an important role in addressing and helping overcome the Covid-19 pandemic, thanks to the latest innovations in the space of biopharma and biotech. This study will explore how the utilization of Blockchain can help to address medical data security concerns to accelerate the utilization of digital health and Telemedicine, which is one of the key concerns cited by both the general public and industry experts, which might impact the adoption of the industrial 4.0 technologies. This research focuses on the Singapore medical industry and on the opinions of Singaporeans and the predictions of industry experts. Using qualitative methodology, this research is exploratory in nature, given the early-stage developments in the implementation of integrated 4.0 technologies in the digital health space. In addition, this study aims to assess the future potential benefits of integrating these advanced technologies into the medical and biopharma industries for the healthcare system of Singapore and its citizens. Finally, this study will seek to contribute to the existing literature in the fields of digital health, Blockchain-based health devices, Internet of Medical Things (IoMT), and Telemedicine, and to the integrated use of these technologies to create new value innovation opportunities and business models in the rapidly expanding digital health space of Singapore.
Keywords: Digital health, IoMT, Internet of medical things, Singapore, Telemedicine, innovation 4.0 technologies, Blockchain, Sharing of medical data with employers, Medical data integrity.
